Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2543.74%
operating margin TTM
-1242.5%
revenue TTM
150.24 Million
revenue per share TTM
7.07$
valuation ratios | |
|---|---|
| pe ratio | -1.95 |
| peg ratio | -0.13 |
| price to book ratio | -363.63 |
| price to sales ratio | 21.92 |
| enterprise value multiple | -2.42 |
| price fair value | -363.63 |
profitability ratios | |
|---|---|
| gross profit margin | 77.8% |
| operating profit margin | -1242.5% |
| pretax profit margin | -2543.74% |
| net profit margin | -2543.74% |
| return on assets | -114.79% |
| return on equity | -314.08% |
| return on capital employed | -70.52% |
liquidity ratios | |
|---|---|
| current ratio | 4.70 |
| quick ratio | 4.70 |
| cash ratio | 4.55 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 18.79 |
| days of payables outstanding | 426.22 |
| cash conversion cycle | -407.44 |
| receivables turnover | 19.43 |
| payables turnover | 0.86 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | -3.42 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.41 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -12.05 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.50 |
| cash per share | 1.50 |
| operating cash flow per share | -0.49 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -12.05 |
| short term coverage ratios | -35.65 |
| capital expenditure coverage ratio | -221.64 |
Frequently Asked Questions
When was the last time CAMP4 Therapeutics Corporation (NASDAQ:CAMP) reported earnings?
CAMP4 Therapeutics Corporation (CAMP) published its most recent earnings results on 13-08-2026.
What is CAMP4 Therapeutics Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. CAMP4 Therapeutics Corporation (NASDAQ:CAMP)'s trailing twelve months ROE is -314.08%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. CAMP4 Therapeutics Corporation (CAMP) currently has a ROA of -114.79%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CAMP's net profit margin stand at?
CAMP reported a profit margin of -2543.74% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CAMP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.70 in the most recent quarter. The quick ratio stood at 4.70, with a Debt/Eq ratio of -3.42.